CopyMark Law Group
4.9/5
Drawing for CORTEXYME

USPTO serial 86847172

CORTEXYME

Reviewed by CopyMark Law Group

Reg. 5007662Status 702Renewal
Filing date
Status date
Registration date
Jul 26, 2016
Examiner
JOINER, KATINA JACKSON
Law office
TMEG LAW OFFICE 104

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with CORTEXYME?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey Greene

Jeffrey Greene Foley & Lardner LLP90 Park AvenueNew York, NY 10016-1314United States

Goods and services

ClassDescriptionStatusFirst use
042Medical research; medical research services in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultationACTIVEOct 23, 2013

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Sep 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 23, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 23, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 12, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jan 12, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jan 12, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 26, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 27, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Jul 26, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 9, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 9, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 9, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 9, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 12, 2018CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 12, 2018COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 26, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 10, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 28, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 28, 2016DOCKASSIGNED TO EXAMINER—
Dec 17, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance